CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $115.75 billion. The enterprise value is $182.17 billion.
| Market Cap | 115.75B |
| Enterprise Value | 182.17B |
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Apr 23, 2026 |
Share Statistics
CVS Health has 1.28 billion shares outstanding. The number of shares has increased by 1.07% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 89.37% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 39.48 and the forward PE ratio is 11.89. CVS Health's PEG ratio is 1.00.
| PE Ratio | 39.48 |
| Forward PE | 11.89 |
| PS Ratio | 0.29 |
| Forward PS | 0.28 |
| PB Ratio | 1.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.64 |
| P/OCF Ratio | 11.19 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.82, with an EV/FCF ratio of 24.64.
| EV / Earnings | 62.13 |
| EV / Sales | 0.45 |
| EV / EBITDA | 11.82 |
| EV / EBIT | 16.80 |
| EV / FCF | 24.64 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.01.
| Current Ratio | 0.87 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 4.25 |
| Debt / FCF | 10.60 |
| Interest Coverage | 3.49 |
Financial Efficiency
Return on equity (ROE) is 3.75% and return on invested capital (ROIC) is 6.30%.
| Return on Equity (ROE) | 3.75% |
| Return on Assets (ROA) | 2.67% |
| Return on Invested Capital (ROIC) | 6.30% |
| Return on Capital Employed (ROCE) | 6.51% |
| Weighted Average Cost of Capital (WACC) | 5.92% |
| Revenue Per Employee | $1.35M |
| Profits Per Employee | $9,773 |
| Employee Count | 300,000 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 19.99 |
Taxes
In the past 12 months, CVS Health has paid $554.00 million in taxes.
| Income Tax | 554.00M |
| Effective Tax Rate | 16.03% |
Stock Price Statistics
The stock price has increased by +41.51% in the last 52 weeks. The beta is 0.62, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +41.51% |
| 50-Day Moving Average | 82.39 |
| 200-Day Moving Average | 78.52 |
| Relative Strength Index (RSI) | 54.60 |
| Average Volume (20 Days) | 8,704,951 |
Short Selling Information
The latest short interest is 19.52 million, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 19.52M |
| Short Previous Month | 18.35M |
| Short % of Shares Out | 1.53% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 2.21 |
Income Statement
In the last 12 months, CVS Health had revenue of $405.62 billion and earned $2.93 billion in profits. Earnings per share was $2.30.
| Revenue | 405.62B |
| Gross Profit | 54.30B |
| Operating Income | 10.85B |
| Pretax Income | 3.46B |
| Net Income | 2.93B |
| EBITDA | 15.41B |
| EBIT | 10.85B |
| Earnings Per Share (EPS) | $2.30 |
Balance Sheet
The company has $11.80 billion in cash and $78.35 billion in debt, with a net cash position of -$66.54 billion or -$52.15 per share.
| Cash & Cash Equivalents | 11.80B |
| Total Debt | 78.35B |
| Net Cash | -66.54B |
| Net Cash Per Share | -$52.15 |
| Equity (Book Value) | 77.64B |
| Book Value Per Share | 60.85 |
| Working Capital | -11.59B |
Cash Flow
In the last 12 months, operating cash flow was $10.33 billion and capital expenditures -$2.94 billion, giving a free cash flow of $7.39 billion.
| Operating Cash Flow | 10.33B |
| Capital Expenditures | -2.94B |
| Depreciation & Amortization | 4.57B |
| Net Borrowing | -1.70B |
| Free Cash Flow | 7.39B |
| FCF Per Share | $5.80 |
Margins
Gross margin is 13.39%, with operating and profit margins of 2.67% and 0.72%.
| Gross Margin | 13.39% |
| Operating Margin | 2.67% |
| Pretax Margin | 0.85% |
| Profit Margin | 0.72% |
| EBITDA Margin | 3.80% |
| EBIT Margin | 2.67% |
| FCF Margin | 1.82% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 2.93%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 2.93% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 115.88% |
| Buyback Yield | -1.07% |
| Shareholder Yield | 1.87% |
| Earnings Yield | 2.54% |
| FCF Yield | 6.39% |
Analyst Forecast
The average price target for CVS Health is $102.85, which is 13.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $102.85 |
| Price Target Difference | 13.37% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 3.81% |
| EPS Growth Forecast (3Y) | 80.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.35 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.35 |
| Piotroski F-Score | 6 |